iiinova — where your digital self keeps evolving

Reposted by Tim Elliott

Tumour-Immune Cell Dynamics Lab @witherslab.bsky.social · 02/04/2026

This week we attended the @oxfordcancer.bsky.social and the @britsocimm.bsky.social -Oxford symposium 👩🏼‍💻🗒️👨‍💻 We are proud to share that at BSI-Oxford, our PostDoc @nabinapun.bsky.social won the prize for the best talk & our RA Paul won the best poster! 💪🏆🎉👏 Withers lab represent!

1105

Tim Elliott @timmunologist.bsky.social · 04/01/2026

Already getting stuck in to an awesome 2026 with DPhil triage interviews starting on Monday for our CRUK centre core funded programme in Cancer Sciences with a pathway in cancer immunology.

061

Tim Elliott @timmunologist.bsky.social · 12/12/2025

Great to see that @oxcio.bsky.social Max is thinking big before his DPhil viva this morning! #croissantasaurusrex

061

Tim Elliott @timmunologist.bsky.social · 08/12/2025

Great discussion - patient groups are central to A/I partnerships -especially in the ED/prevention space….

063

Tim Elliott @timmunologist.bsky.social · 01/12/2025

Congratulations Liz! Read her historical perspective article in @imtadvances.bsky.social

031

Tim Elliott @timmunologist.bsky.social · 01/12/2025

Congress starts today in Liverpool. Immunologists are battling the elements to be together! See you there.

020

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 13/11/2025

🧬 Therapeutic cancer vaccines are back in focus! Advances in neo-antigen T cells, dendritic cell biology, and mRNA tech are paving the way for next-gen immunotherapy. Read the Open Access review: bit.ly/4cefxGm #CancerVaccines #Immunotherapy #mRNA #Oncology

022

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 07/11/2025

🦠 DC3s in solid tumours can prime T cells and influence outcomes—boosting survival in some cancers, but promoting immunosuppression in others. 👉 bit.ly/3T2blRg #Immunotherapy #CancerImmunology

022

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 06/11/2025

🔬 First head-to-head comparison of nuclear imaging for tumour CD8⁺ T cells shows [⁸⁹Zr]Zr-anti-CD8-IgG2a(silent) & [⁸⁹Zr]Zr-OT-I track T-cell infiltration & migration, aiding immunotherapy strategies. 👉 bit.ly/4ncWCzv #Immunotherapy #CD8Tcells #CancerResearch

013

Reposted by Tim Elliott

Oxford Cancer @oxfordcancer.bsky.social · 03/11/2025

Congratulations, Michael! 🎉

001

Reposted by Tim Elliott

Prof John Gordon @profcelentyx.bsky.social · 24/10/2025

Incredible #infection #immunity #cancer #Bcells #Tcells Resource 👏 Top of the Human League 🙋‍♂️🙋‍♀️

021

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 22/10/2025

From CAR-NK cells to checkpoint inhibitors, Blunt & Khakoo review how boosting NK-cell function could transform cancer therapy. 🔓 Open access: bit.ly/4j8dKEW #Immunotherapy #NKcells #CancerResearch

042

Reposted by Tim Elliott

Malcolm Sim @mjwsim.bsky.social · 23/10/2025

UK NK 2026 in Cardiff. January 9th. Be there. eventbrite.co.uk/e/uk-nk-confer… Hosted by Rich Stanton, Ceri Fielding & Eddie Wang

eventbrite.co.uk

053

Reposted by Tim Elliott

British Society for Immunology @britsocimm.bsky.social · 23/10/2025

Need funding to attend your next conference? 💡 The BSI Conference Travel Grants can cover your travel costs - UK (£500), Europe (£700), rest of world (£1,000). The deadline is just over 1 week away (1 November), so submit your application soon! bit.ly/3U0jk2E

063

Tim Elliott @timmunologist.bsky.social · 24/10/2025

Tick what? Many happy returns Felipe and well marked Anjum!

010

Reposted by Tim Elliott

Society for Immunotherapy of Cancer @sitcancer.bsky.social · 23/10/2025

4 decades of IO – Celebrating 40 years of SITC. In 2009, we had a record meeting attendance and abstract submission! Attend this year's 40th Anniversary Annual Meeting and be a part of the science. www.sitcancer.org/2025/home

021

Reposted by Tim Elliott

Caetano Reis e Sousa @reisesousalab.bsky.social · 23/10/2025

Wonderful day celebrating Paul Nurse after he steps down from being the Director @crick.ac.uk. We are all very grateful to him for having created an amazing institute.

0181

Reposted by Tim Elliott

Françoise Howe @francoiseshowe.bsky.social · 19/07/2025

Great to see our work on preventive cancer vaccines, including LungVax, featured in this issue! @oxfordcancer.bsky.social @sarahblagden.bsky.social @timmunologist.bsky.social

042

Reposted by Tim Elliott

Oxford Cancer @oxfordcancer.bsky.social · 18/07/2025

Join us for our DPhil in Cancer Science Open Day on Tuesday 2nd September at 12:30pm to find out how a DPhil can be the next step in your cancer research career development! Register via our Eventbrite link before 1st Sept⬇️ @oncology.ox.ac.uk @medsci.ox.ac.uk www.eventbrite.co.uk/e/university...

eventbrite.co.uk

University of Oxford - DPhil in Cancer Science Open Day

Join the Virtual DPhil in Cancer Science Open Day to hear more about Oxford’s world-leading research training

002

Tim Elliott @timmunologist.bsky.social · 17/07/2025

Looking forward to talking about #cancervaccines to *all* @CRUK research and innovation staff this afternoon at their fabulous away-day. Actually I’m a bit nervous😬

190

Reposted by Tim Elliott

Hallou Lab @halloulab.bsky.social · 16/07/2025

Amazing news for our Institute @kiroxford.bsky.social @ox.ac.uk 🎉🍾😀 ! Looking forward to working with our @manchester.ac.uk colleagues to understand better how envrionmental determinants drive chronic inflammatory diseases !

061

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 15/07/2025

Targeting monocyte dynamics in MS? In Immunotherapy Advances, Bibi et al. explore how shifting monocytes from inflammatory to reparative states may reshape MS treatment strategies. 📘 bit.ly/3EXOfaV #MS #Monocytes #Neuroinflammation

011

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 14/07/2025

New research by Rui Zhao et al. shows that high anti-drug antibody (ADA) levels after 3 cycles of camrelizumab are linked to shorter survival in patients with advanced solid cancers. 📉 Higher ADA = lower drug levels = worse outcomes. 🔗 bit.ly/461mc5B #Immunotherapy #CancerResearch

001

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 04/07/2025

🧬 Better understanding of immune rejection and evasion is setting the stage for next-gen therapies. Elizabeth Simpson reviews how foundational immunology is reshaping transplant and cancer treatment. 📖 bit.ly/44N141N #TransplantImmunology #Immunotherapy

011

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 06/07/2025

🧩 Antigen presentation is complex - but imaging is bringing clarity. @doreenlau.bsky.social‬ & @timmunologist.bsky.social‬ review how advanced imaging illuminates T-cell–APC interactions, peptide-MHC dynamics, and more in cancer immunity. 📖 bit.ly/3TkIasN #CancerImmunology

0184

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 10/07/2025

A high-affinity TCRxCD3 bispecific (ImmTAC®) efficiently redirects T cells to kill PRAME+ tumor cells, even at low epitope density. Combination with anti-PD-1 restores activity in exhausted T cells. One of the most read articles in ITA: bit.ly/40o5kT8 #immunology

001

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 11/07/2025

Mechanistic modelling reveals that both antigen-dependent and independent factors shape CAR T-cell dynamics in month-one lymphoma patients. IL-7/IL-15 levels and lymphodepletion matter more than CAR T-cell phenotype. 📖 Read: bit.ly/3U6fDY6 #Immunotherapy

043

Reposted by Tim Elliott

Centre for Immuno-Oncology @oxcio.bsky.social · 10/07/2025

Yesterday we finished with prize-giving and drinks in the garden🥂🌱! 🏆 Posters for Bas, Cindy & Charlotte📃; postdoc talk for Qian 👩‍🏫 & best embossing artwork for Group8 🧑‍🎨 Shoutout to Lisha for the Rhodes House tours, acknowledging its history, the good and the uncomfortable ⚖️. What a day! #CIOawayday

063

Reposted by Tim Elliott

Centre for Immuno-Oncology @oxcio.bsky.social · 09/07/2025

✨ Kicking off #CIOawayday with our senior PIs sharing the experiments that changed their careers 🧑‍🔬👩‍🔬🧫 A reminder that serendipity, curiosity, and pub chats can spark groundbreaking ideas 🤓 Clearly science thrives on kindness and collaboration and we got a lot of that in #CIO 😉🙃 #ScienceLife

095

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 12/07/2025

🔬 Call for papers: We invite submissions for a special collection on Immunotherapies for Inborn Errors of Immunity. Explore genetics-guided, targeted treatments for primary immunodeficiency and immune dysregulation. 🗓️ Submit by Sept 2025 📖 Info: bit.ly/40o5kT8 #Immunotherapy

001

Reposted by Tim Elliott

Patrick McGuire @handle.invalid · 12/07/2025

#Bridge2ABetterFuture Challenge #10 complete with sueduncombe.bsky.social - the @cancerresearch.uk.org Big Hike (Cotswolds). 14 miles over the hills in the heatwave! Big steps bringing big discoveries Thanks for all donations fundraise.cancerresearchuk.org/page/bridge-... @oxfordcancer.bsky.social

032

Tim Elliott @timmunologist.bsky.social · 05/07/2025

Wonderful personal perspective from one of the founders of modern immunology

030

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 27/06/2025

🚨 Last chance! Just a few days left to submit to our Special Collection: Imaging in Immunotherapy. Showcase your research in molecular imaging, immune monitoring, and image-guided drug delivery. Deadline: June 2025 🧬🖼️ #Immunotherapy #MolecularImaging 📩 Submit now: bit.ly/4j8c265

011

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 25/06/2025

🚨 Researchers at over 120 UK institutions can publish open access for free in Immunotherapy Advances! No APC's, just impactful immunotherapy research shared with the world. 🌐 #OpenScience 🔗 Check eligibility here: bit.ly/4no9OTy

021

Reposted by Tim Elliott

Immunotherapy Advances @imtadvances.bsky.social · 26/06/2025

🫁 New study: M2 macrophages ease asthma symptoms in mice by boosting IL-10⁺ B-cell production via the TGF-β & oxidative phosphorylation pathways. 💡 Highlights the regulatory role of macrophage–B cell interactions in asthma. 🔗 Read more: bit.ly/4kXzogj

021

Reposted by Tim Elliott

Centre for Immuno-Oncology @oxcio.bsky.social · 26/06/2025

A big part of the CIO team will be at #BSI2025 🤓 especially now that our very own Max from the @ggillesp.bsky.social lab is featured on the conference poster! Looking forward to an exciting few days in Liverpool 🔬✨ #Immunology #CIOonTour

063

Reposted by Tim Elliott

Oxford Cancer @oxfordcancer.bsky.social · 26/06/2025

And we're off! Conference Co-Chair and @oncology.ox.ac.uk's Professor of Experimental Oncology @sarahblagden.bsky.social opens day two of the Cancer Prevention Research Conference in London.

033

Tim Elliott @timmunologist.bsky.social · 26/06/2025

Intramolecular Active displacement of common MHC I- peptide interactions drives peptide editing. Thanks for the call out Chris!

020

Tim Elliott @timmunologist.bsky.social · 25/06/2025

Really important to see the research generating a solid and powerful evidence base needed to help governments undo health inequalities

050

Tim Elliott @timmunologist.bsky.social · 25/06/2025

It’s under publicised that MANY universities and institutions around the world can publish in ITA for FREE under the read and publish deals with OUP. There are still inequalities - especially painful for BRIC who have great research infrastructure but no R&P deals yet. I hope this will change.

020

Reposted by Tim Elliott

Stephen Turner @stephenturner.us · 02/10/2024

Review: From computational models of the splicing code to regulatory mechanisms and therapeutic implications www.nature.com/articles/s41576-024-… (read free: rdcu.be/dVNV4)

063

Reposted by Tim Elliott

Oxford Cancer @oxfordcancer.bsky.social · 25/06/2025

Great panel discussion chaired by our own @timmunologist.bsky.social on 'the role of immune dysfunction in cancer development and prevention' at today's Cancer Prevention Research Conference! @cancerresearchuk.org @americancancersoc.bsky.social

041

Tim Elliott @timmunologist.bsky.social · 25/06/2025

Immunology x cancer prevention = exciting research x healthy living

020

Reposted by Tim Elliott

Centre for Immuno-Oncology @oxcio.bsky.social · 20/06/2025

Feeling proud and looking sharp! Repping the Centre for Immuno-Oncology in style 😎 🔥Our top models, @anthonyhsieh.bsky.social and @mjwsim.bsky.social, rocking the CIO polos, in black and navy, which seems to be the unofficial Friday uniform around here! Team spirit (and outfits) on point 💛🖤💙

062